Drugs that contain Asenapine Maleate

1. List of Saphris drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7741358 ALLERGAN Crystal form of asenapine maleate
Apr, 2026

(3 years from now)

US8022228 ALLERGAN Crystal form of asenapine maleate
Apr, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7741358

(Pediatric)

ALLERGAN Crystal form of asenapine maleate
Oct, 2026

(3 years from now)

US8022228

(Pediatric)

ALLERGAN Crystal form of asenapine maleate
Oct, 2026

(3 years from now)

Market Authorisation Date: 13 August, 2009

Treatment: Use of the atypical antipsychotic asenapine for treatment of schizophrenia in adults; Treatment of bipolar disorder and schizophrenia; Use of the atypical antipsychotic asenapine for treatment of manic or mixed episodes of bipolar i disorder: as adjunctive treatment to lithium or valproate in adults; Use of the atypical antipsychotic asenapine for treatment of manic or mixed episodes of bipolar i disorder: acute monotherapy of manic or mixed episodes in pediatric patients age 10-17; Use of the atypical antipsychotic asenapine for treatment of manic or mixed episodes of bipolar i disorder: acute monotherapy of manic or mixed episodes (ages 10 to adult); Method of treating manic or mixed episodes associated with bipolar disorder in pediatric patients; Use of the atypical antipsychotic asenapine for treatment of manic or mixed episodes of bipolar i disorder: maintenance monotherapy in adults

Dosage: TABLET;SUBLINGUAL

How can I launch a generic of SAPHRIS before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in